Moreover, Abouantoun and co-workers showed PDGFRB tyrosine kinase activity is critical for migration and invasion of medulloblastoma cells, possibly by trans-activating EGFR, and thus its depletion may represent an important therapeutic strategy for the treatment of this cancer [30]. This evidence concerns the gene PDGFRB and cancer.